Unknown

Dataset Information

0

Generation of stem cell-derived β-cells from patients with type 1 diabetes.


ABSTRACT: We recently reported the scalable in vitro production of functional stem cell-derived β-cells (SC-β cells). Here we extend this approach to generate the first SC-β cells from type 1 diabetic patients (T1D). β-cells are destroyed during T1D disease progression, making it difficult to extensively study them in the past. These T1D SC-β cells express β-cell markers, respond to glucose both in vitro and in vivo, prevent alloxan-induced diabetes in mice and respond to anti-diabetic drugs. Furthermore, we use an in vitro disease model to demonstrate the cells respond to different forms of β-cell stress. Using these assays, we find no major differences in T1D SC-β cells compared with SC-β cells derived from non-diabetic patients. These results show that T1D SC-β cells could potentially be used for the treatment of diabetes, drug screening and the study of β-cell biology.

SUBMITTER: Millman JR 

PROVIDER: S-EPMC4866045 | BioStudies | 2016-01-01

SECONDARY ACCESSION(S): GSE70901

REPOSITORIES: biostudies

Similar Datasets

2016-04-01 | E-GEOD-70901 | ArrayExpress
2008-01-01 | S-EPMC2872108 | BioStudies
2011-01-01 | S-EPMC5706467 | BioStudies
2009-01-01 | S-EPMC2627485 | BioStudies
| GSE94382 | GEO
2016-01-01 | S-EPMC5584070 | BioStudies
1000-01-01 | S-EPMC3438879 | BioStudies
2011-01-01 | S-EPMC3591677 | BioStudies
2016-02-24 | PXD000859 | Pride
2015-01-01 | S-EPMC4599944 | BioStudies